← Eichor
Study identifier: NCT06164769 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery

Condition: Tumor of Pancreas · Surgical Blood Loss  ·  Sponsor: Zhejiang University

PhaseNA
Planned participants30
Who can joinAll sexes, 14 Years to 70 Years
Healthy volunteersNo

About this study

Pancreatic enucleation could preserve more healthy pancreatic tissues and functions with a low recurrence risk. However, conventional enucleation can cause significant intraoperative bleeding, especially in which tumors in the pancreatic head, neck, and uncinate process of pancreas, as these tissues are rich in blood supply, mainly including the abdominal trunk and the superior mesenteric artery. In this study, we developed a novel method to control the pancreatic blood flow in laparoscopic enucleation--blocking the abdominal trunk and superior mesenteric artery with vascular occlusion clips in the process of resection, and evaluated its effectiveness and safety.

This description comes directly from the study's public registry record.

Talk to the study team

Sheng Yan, professor  ·  +86-13957161680  ·  shengyan@zju.edu.cn

Bo Zhou, Dr.  ·  +86-13758229594  ·  zjuzhoubo@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

the Second Affiliated Hospital of Zhejiang UniversityHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06164769